QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01315249 · COMPLETED
Trial details
- NCT number
- NCT01315249
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2012-03-01
- Enrollment
- 523
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.